CN102525960B - 泮托拉唑钠药物组合物及其制备方法 - Google Patents
泮托拉唑钠药物组合物及其制备方法 Download PDFInfo
- Publication number
- CN102525960B CN102525960B CN 201210012312 CN201210012312A CN102525960B CN 102525960 B CN102525960 B CN 102525960B CN 201210012312 CN201210012312 CN 201210012312 CN 201210012312 A CN201210012312 A CN 201210012312A CN 102525960 B CN102525960 B CN 102525960B
- Authority
- CN
- China
- Prior art keywords
- pantoprazole sodium
- add
- minutes
- pantoprazole
- recipe quantity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229960004048 pantoprazole sodium Drugs 0.000 title claims abstract description 45
- YNWDKZIIWCEDEE-UHFFFAOYSA-N pantoprazole sodium Chemical compound [Na+].COC1=CC=NC(CS(=O)C=2[N-]C3=CC=C(OC(F)F)C=C3N=2)=C1OC YNWDKZIIWCEDEE-UHFFFAOYSA-N 0.000 title claims abstract description 45
- 239000000203 mixture Substances 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims abstract description 17
- 229930195725 Mannitol Natural products 0.000 claims abstract description 17
- 235000010355 mannitol Nutrition 0.000 claims abstract description 17
- 239000000594 mannitol Substances 0.000 claims abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 16
- 238000004108 freeze drying Methods 0.000 claims abstract description 13
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 claims abstract description 13
- 239000000243 solution Substances 0.000 claims description 18
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 16
- 239000008215 water for injection Substances 0.000 claims description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 229940079593 drug Drugs 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- -1 2-hydroxypropyl Chemical group 0.000 claims description 5
- 229920000858 Cyclodextrin Polymers 0.000 claims description 5
- 239000001116 FEMA 4028 Substances 0.000 claims description 5
- 229960004853 betadex Drugs 0.000 claims description 5
- 238000005261 decarburization Methods 0.000 claims description 5
- 238000005374 membrane filtration Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 abstract description 5
- 238000002347 injection Methods 0.000 abstract description 5
- 229950008882 polysorbate Drugs 0.000 abstract 1
- 229920000136 polysorbate Polymers 0.000 abstract 1
- 239000000843 powder Substances 0.000 description 12
- IQPSEEYGBUAQFF-UHFFFAOYSA-N Pantoprazole Chemical compound COC1=CC=NC(CS(=O)C=2NC3=CC=C(OC(F)F)C=C3N=2)=C1OC IQPSEEYGBUAQFF-UHFFFAOYSA-N 0.000 description 9
- 229960005019 pantoprazole Drugs 0.000 description 9
- 239000000126 substance Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 3
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- MMJMSRMOAUITKN-UHFFFAOYSA-N 2-sulfinylbenzimidazole Chemical compound C1=CC=CC2=NC(=S=O)N=C21 MMJMSRMOAUITKN-UHFFFAOYSA-N 0.000 description 1
- JGSARLDLIJGVTE-UHFFFAOYSA-N 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-UHFFFAOYSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- USMPTFAUWRWMFC-UHFFFAOYSA-N [Na].S(=O)=C1NC2=C(N1)C=CC=C2 Chemical compound [Na].S(=O)=C1NC2=C(N1)C=CC=C2 USMPTFAUWRWMFC-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940126409 proton pump inhibitor Drugs 0.000 description 1
- 239000000612 proton pump inhibitor Substances 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- 210000002438 upper gastrointestinal tract Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210012312 CN102525960B (zh) | 2012-01-16 | 2012-01-16 | 泮托拉唑钠药物组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210012312 CN102525960B (zh) | 2012-01-16 | 2012-01-16 | 泮托拉唑钠药物组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102525960A CN102525960A (zh) | 2012-07-04 |
CN102525960B true CN102525960B (zh) | 2013-03-20 |
Family
ID=46334794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210012312 Active CN102525960B (zh) | 2012-01-16 | 2012-01-16 | 泮托拉唑钠药物组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102525960B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102920667A (zh) * | 2012-11-06 | 2013-02-13 | 海南中化联合制药工业股份有限公司 | 注射用泮托拉唑纳米粒冻干制剂及其制备方法 |
CN104721190B (zh) * | 2015-03-26 | 2017-01-11 | 新乡医学院 | 头孢替唑钠注射液及其制备方法 |
CN106474074B (zh) * | 2015-09-02 | 2021-02-09 | 山东新时代药业有限公司 | 一种注射用左旋泮托拉唑钠冻干粉制剂 |
CN106474075B (zh) * | 2015-09-02 | 2021-02-09 | 山东新时代药业有限公司 | 注射用左旋泮托拉唑钠冻干粉组合物及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101229138A (zh) * | 2008-01-18 | 2008-07-30 | 山东罗欣药业股份有限公司 | 一种泮托拉唑钠冻干粉针剂及其制备方法 |
CN101810588A (zh) * | 2009-11-19 | 2010-08-25 | 罗诚 | 一种注射用泮托拉唑钠冻干药物组合物及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
-
2012
- 2012-01-16 CN CN 201210012312 patent/CN102525960B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101229138A (zh) * | 2008-01-18 | 2008-07-30 | 山东罗欣药业股份有限公司 | 一种泮托拉唑钠冻干粉针剂及其制备方法 |
CN101810588A (zh) * | 2009-11-19 | 2010-08-25 | 罗诚 | 一种注射用泮托拉唑钠冻干药物组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102525960A (zh) | 2012-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102525960B (zh) | 泮托拉唑钠药物组合物及其制备方法 | |
CN102357082A (zh) | 一种埃索美拉唑钠的冻干粉针剂及其制备方法 | |
CN101244043A (zh) | 比伐卢定冻干粉针剂及其制备方法 | |
CN101703483B (zh) | 一种奥美拉唑钠冻干粉针剂及其制备方法 | |
CN103417499A (zh) | 生长抑素冻干粉针的制备方法 | |
CN102796078B (zh) | 一种泮托拉唑化合物、制备方法及其药物制剂 | |
CN103520121A (zh) | 注射用维库溴铵冻干粉针剂及其制备方法 | |
CN105663127B (zh) | 注射用冷冻干燥法莫替丁组合物 | |
CN103202816B (zh) | 泮托拉唑钠冻干粉针剂 | |
CN102657622A (zh) | 一种含有埃索美拉唑钠的冻干粉针剂的制备工艺 | |
CN102670524B (zh) | 一种注射用泮托拉唑钠冻干制剂及其制备方法 | |
CN103919737B (zh) | 一种雷贝拉唑钠冻干粉针剂及其制备方法 | |
CN103845295A (zh) | 一种注射用帕洛诺司琼制剂及其制备方法 | |
CN102600088A (zh) | 一种供注射用的兰索拉唑药物组合物及其制备方法 | |
CN102440967A (zh) | 一种注射用雷贝拉唑钠及其制备方法和检测方法 | |
CN114028346A (zh) | 注射用奥美拉唑钠及其制备方法 | |
CN103565747B (zh) | 一种埃索美拉唑药物组合物及其制备方法 | |
CN102552179B (zh) | 一种雷贝拉唑钠组合物冻干粉针及其制备方法 | |
CN101623262B (zh) | 一种五水头孢唑啉钠前体脂质体制剂 | |
CN105853377B (zh) | 一种注射用雷贝拉唑钠制剂及其制备方法 | |
CN101804034B (zh) | 一种雷贝拉唑钠粉针剂及其制备方法 | |
CN104610227A (zh) | 一种埃索美拉唑镁多晶型化合物的高压水热制备法 | |
CN105218522B (zh) | 一种右旋艾普拉唑化合物及其药物组合物 | |
CN104666254A (zh) | 泮托拉唑钠冻干粉针剂药物组合物和制法 | |
CN102670526B (zh) | 奥沙利铂冻干粉针剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120704 Assignee: Maanshan Fengyuan Pharmaceutical Co.,Ltd. Assignor: Hubei Neo-Treation Pharmaceutical Co., Ltd. Contract record no.: 2014420000022 Denomination of invention: Pantoprazole sodium medicine composition for injection and preparation method thereof Granted publication date: 20130320 License type: Exclusive License Record date: 20140324 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
ASS | Succession or assignment of patent right |
Owner name: MAANSHAN FENGYUAN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: HUBEI NEO-TREATION PHARMACEUTICAL CO., LTD. Effective date: 20141224 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 430014 WUHAN, HUBEI PROVINCE TO: 243000 MAANSHAN, ANHUI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141224 Address after: 243000, No. 1503, Mei Shan Road, Ma'anshan economic and Technological Development Zone, Anhui Patentee after: Maanshan Fengyuan Pharmaceutical Co.,Ltd. Address before: 430014, Zhenghe Plaza, 707 Zhongshan Avenue, Jiang'an District, Hubei, Wuhan, 1506 Patentee before: Hubei Neo-Treation Pharmaceutical Co., Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20190313 Address after: 432500 Yunmeng County Economic Development Zone, Xiaogan, Hubei Patentee after: Hubei Merryclin Pharmaceutical Co., Ltd. Address before: 243000 Meishan Road 1503, Maanshan Economic and Technological Development Zone, Anhui Province Patentee before: Maanshan Fengyuan Pharmaceutical Co.,Ltd. |
|
TR01 | Transfer of patent right |